A retrospective study exploring the safety and efficacy of hepatic arterial infusion chemotherapy and sequential transarterial embolization combined with lenvatinib and tislelizumab in unresectable hepatocellular carcinoma

被引：0

作者：

Zhong, Jian-Hong ^{[1
]}

Chen, Zu-Shun ^{[1
]}

Qi, Lu-Nan ^{[1
]}

Zhang, Zhi-Ming ^{[1
]}

Xiang, Bang-De ^{[1
]}

Ma, Liang ^{[1
]}

机构：

[1] Guangxi Med Univ Canc Hosp, Nanning, Peoples R China

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e16219

引用

页数：1

共 50 条

[41] Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study
Lee, Jaejun
Han, Ji-Won
Sung, Pil-Soo
Lee, Soon-Kyu
Yang, Hyun
Nam, Hee-Chul
Yoo, Sun-Hong
Lee, Hae-Lim
Kim, Hee-Yeon
Lee, Sung-Won
Kwon, Jung-Hyun
Jang, Jeong-Won
Kim, Chang-Wook
Nam, Soon-Woo
Oh, Jung-Suk
Chun, Ho-Jong
Bae, Si-Hyun
Choi, Jong-Young
Yoon, Seung-Kew
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
[42] Efficacy and safety of transarterial chemoembolization in combination with lenvatinib and tislelizumab for patients with unresectable BCLC-B stage hepatocellular carcinoma classified as beyond up to seven criteria: A retrospective study
Chen, Song
Guo, Wenbo
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[43] Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma
Tsai, Wei-Lun
Lai, Kwok-Hung
Liang, Huei-Lung
Hsu, Ping-I
Chan, Hoi-Hung
Chen, Wen-Chi
Yu, Hsien-Chung
Tsay, Feng-Woei
Wang, Huay-Min
Tsai, Hung-Chih
Cheng, Jin-Shiung
PLOS ONE, 2014, 9 (05):
[44] Hepatic arterial infusion chemotherapy with or without lenvatinib for unresectable cholangiocarcinoma: a single-center retrospective study
Wang, Yajing
Wei, Zhanqi
Zhang, Zheng
Xu, Jingyi
Wang, Yaqin
Chen, Qian
Zhang, Yuewei
HEPATIC ONCOLOGY, 2023, 10 (02)
[45] Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study
Hiramine, Yasunari
Uto, Hirofumi
Imamura, Yasushi
Tabu, Kazuaki
Baba, Yoshirou
Hiwaki, Takuya
Sho, Yukihiko
Tahara, Kenji
Higashi, Hirofumi
Tamai, Tutomu
Oketani, Makoto
Ido, Akio
Tsubouchi, Hirohito
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (03) : 433 - 441
[46] Efficacy and safety of irinotecan-eluting HepaSphere transarterial chemoembolization combined with hepatic arterial infusion chemotherapy for unresectable colorectal liver metastases
Feng, Aiwei
Gao, Song
Guo, Jianhai
Kou, Fuxin
Liu, Shaoxing
Zhang, Xin
Liu, Baojiang
Wang, Xiaodong
Chen, Hui
Xu, Haifeng
Liu, Peng
Cao, Guang
Gao, Qinzong
Zhu, Xu
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[47] Application of arterial infusion ports in hepatic arterial infusion chemotherapy and embolization for advanced hepatocellular carcinoma
Han, Xinqiang
Zhao, Peng
Wang, Xuemin
Tan, Xiaoyu
Zhang, Yongzhen
SAUDI MEDICAL JOURNAL, 2023, 44 (12) : 1283 - 1289
[48] Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma
Li, Shaohua
Mei, Jie
Zhao, Rongce
Zhou, Jing
Wang, Qiaoxuan
Lu, Lianghe
Li, Jibin
Zheng, Lie
Wei, Wei
Guo, Rongping
FRONTIERS IN IMMUNOLOGY, 2024, 15
[49] Efficacy and safety of anlotinib combined with transarterial chemoembolization versus transarterial chemoembolization alone in patients with unresectable hepatocellular carcinoma: A retrospective study.
Guo, Wenbo
Chen, Song
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[50] The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Cao, Fei
Yang, Yi
Si, Tongguo
Luo, Jun
Zeng, Hui
Zhang, Zhewei
Feng, Duiping
Chen, Yi
Zheng, Jiaping
FRONTIERS IN ONCOLOGY, 2021, 11

← 1 2 3 4 5 →